Latest news

November 18, 2019

The future of antibiotics depends on all of us

World Antibiotic Awareness Week (WAAW) is WHO initiative which takes place each November and aims to increase global awareness of antibiotic resistance (AMR). It also encourages best practices to avoid the further emergence and spread of AMR. This year’s public messaging focuses on prevention of infections with basic interventions that are applicable in all settings.

September 13, 2019

Bactiguard supports the World Sepsis Day

Sepsis is a global health crisis and every 3-4 seconds someone dies of sepsis. The World Sepsis Day is held on September 13th every year and is an opportunity for people across the world to raise awareness and unite in the fight against sepsis. In our mission to prevent hospital acquired infections and save lives, Bactiguards is one of the main sponsors of the event.

August 15, 2019

What gets Bactiguard's CEO Christian Kinch and his "Bactiguardians" out of bed every morning?

Bactiguard is a Swedish medtech company with a global presence, offering prevention solutions for nosocomial infections, reducing the use of antibiotics and the spread of multi-resistant bacteria. In this article, its CEO Christian Kinch, explains how Bactiguard’s solution works to save lives and reduce healthcare costs. He also shares the company’s international journey in the strategic Indian and Chinese markets, and his plans to grow it into the next Swedish unicorn.

Latest press releases

June 03, 2020

Bactiguard initiates collaboration with online pharmacy Apotea on sales of Hydrocyn® aqua

Bactiguard initiates collaboration with the online pharmacy Apotea on sales of Hydrocyn® aqua (Hydrocyn) to consumers in the Swedish market. Recent tests confirm that Hydrocyn is the first disinfectant on the Swedish market with documentet effect on the new Corona virus causing COVID-19. Sales via Apotea will commence on 5 June.

June 02, 2020

Hydrocyn® aqua inactivates the coronavirus causing COVID-19

The effect of Hydrocyn® aqua (Hydrocyn) on the new coronavirus (SARS-CoV-2) causing COVID-19 has been confirmed. Tests performed by the Swedish National Veterinary Institute show that 99.9% of the virus particles were killed after exposure to Hydrocyn. Bactiguard launched Hydrocyn in the Swedish market in March, with focus on critical societal functions.

May 29, 2020

Increased number of shares and votes in Bactiguard

During May 2020, the number of class B shares in Bactiguard Holding AB (publ) ("Bactiguard") has increased by 241,512. As a result, the total number of shares in the company as of May 29, 2020 amounted to 29,543,885 and the total number of votes to 69,543,885.